nasolacrimal intubation: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by dreye

nasolacrimal intubation Introduction (What it is)

nasolacrimal intubation is a technique that places a small soft tube (a stent) into the tear drainage system.
It is used to help tears flow from the eye into the nose when the normal pathway is narrowed or blocked.
Clinicians most often use it in eye care settings dealing with excessive tearing (epiphora) or tear duct obstruction.
It can be used in children or adults, depending on the underlying cause.

Why nasolacrimal intubation used (Purpose / benefits)

The eye’s surface is continually coated by tears, which normally drain through tiny openings in the eyelids and then into the nose. When this drainage pathway is narrowed or obstructed, tears can spill over the eyelid and run down the cheek. This symptom is commonly called epiphora (watery eyes). In some cases, poor drainage can also contribute to recurrent discharge or infection in the lacrimal sac area.

nasolacrimal intubation is used to support or restore patency (openness) of the tear drainage system. Rather than “creating” a new drainage pathway, the tube typically functions as a temporary scaffold that keeps an existing pathway open while tissues heal or while mild narrowing is overcome.

Common goals and potential benefits include:

Symptom relief: reducing watery eyes by improving tear outflow.
Supporting healing after tear duct procedures: helping maintain an open channel as swelling and scarring settle.
Reducing recurrence of narrowing: keeping canaliculi (small drainage channels) from sticking together during healing.
Preserving anatomy: in selected cases, it may help avoid or delay more invasive surgery, though the best approach varies by clinician and case.
Stabilizing repaired injuries: in canalicular lacerations, it helps maintain alignment of the drainage channel while it heals.

Indications (When ophthalmologists or optometrists use it)

Typical scenarios where nasolacrimal intubation may be considered include:

Congenital nasolacrimal duct obstruction (CNLDO) in infants/children, especially when conservative measures or initial procedures have not fully resolved symptoms (varies by clinician and case).
Partial nasolacrimal duct obstruction in adults, where some flow is present but narrowed.
Canalicular stenosis (narrowing of the canaliculi), including narrowing related to chronic inflammation.
Canalicular laceration due to eyelid trauma, commonly managed by oculoplastic surgeons.
After dacryocystorhinostomy (DCR) or related lacrimal surgery, when a stent is used to support the surgical pathway (use varies by surgeon preference and case).
Functional epiphora in select cases, where anatomy may look open but tear drainage function is still inefficient (evaluation is typically individualized).
Revision situations where prior lacrimal procedures have left scarring or a tendency to re-narrow.

Contraindications / when it’s NOT ideal

nasolacrimal intubation is not suitable for every cause of tearing, and sometimes another approach is more appropriate. Situations where it may be less ideal include:

Complete obstruction that cannot be traversed or adequately opened with standard techniques; a bypass procedure (such as DCR) may be considered instead (varies by clinician and case).
Uncontrolled active infection of the lacrimal sac (dacryocystitis) or surrounding tissues, where infection management may be prioritized before stenting.
Significant nasal pathology (for example, severe septal deviation, problematic turbinate anatomy, nasal polyps, or active nasal infection) that may interfere with placement or tolerance (often co-managed with ENT depending on case).
Suspected lacrimal drainage tumors or masses, where evaluation and biopsy considerations come first.
Material sensitivity or intolerance to the stent material (most commonly silicone; reactions are uncommon but possible).
Poor ability to attend follow-up in contexts where monitoring and timely removal are important (what is required varies by clinician and case).
Tearing from non-drainage causes, such as severe dry eye with reflex tearing, eyelid malposition, or tear film instability; in these cases, treating the underlying driver may be more relevant than intubation.

How it works (Mechanism / physiology)

Relevant anatomy (tear drainage pathway)

Tears typically drain through:

Puncta: tiny openings on the upper and lower eyelid margins near the nose.
Canaliculi: small channels that carry tears from the puncta toward the lacrimal sac (upper and lower canaliculus often join to form a common canaliculus).
Lacrimal sac: a reservoir at the inner corner of the eye.
Nasolacrimal duct: a passage from the lacrimal sac into the nasal cavity (usually opening beneath the inferior turbinate).

Mechanism (what the tube does)

nasolacrimal intubation places a soft, flexible tube—most commonly silicone—through part or all of this drainage system. The stent helps by:

Maintaining an open lumen: keeping a narrowed segment from collapsing or scarring closed.
Guiding tissue healing: allowing the lining of the drainage pathway to heal around an open channel.
Reducing adhesion formation: limiting the chance that inflamed surfaces stick together during healing.
Supporting repaired canaliculi: keeping the torn ends aligned in trauma repair.

The stent does not “treat” all causes of epiphora. For example, if tearing is driven by eyelid malposition (ectropion) or poor lacrimal pump function (reduced blinking-driven drainage), a stent may not address the primary problem.

Onset, duration, and reversibility

Onset: When successful, improved drainage may be noticed relatively soon after swelling subsides, but timelines vary by clinician and case.
Duration: Stents are commonly intended to be temporary, with removal planned after a healing period. The exact duration varies by indication, surgeon preference, and healing response.
Reversibility: The tube can typically be removed in clinic or a procedural setting. Symptom relief after removal depends on whether the underlying narrowing has resolved or recurs.

nasolacrimal intubation Procedure overview (How it’s applied)

nasolacrimal intubation is a clinical procedure performed by trained eye surgeons, commonly in ophthalmology (often oculoplastics) and sometimes in collaboration with ENT for complex nasal anatomy. The exact workflow differs across age groups, indications, and practice settings.

A high-level sequence often looks like this:

Evaluation / exam – History focusing on tearing pattern, infections, discharge, and prior procedures. – Eye and eyelid exam to look for punctal narrowing, eyelid position issues, and ocular surface irritation. – Lacrimal system assessment may include irrigation, probing, or other tests to localize the obstruction (testing choices vary by clinician and case).
Preparation – Anesthesia selection depends on age, complexity, and patient comfort (local anesthesia, sedation, or general anesthesia may be used). – The nasal cavity may be assessed if a nasal retrieval step is expected.
Intervention – A stent is guided through the punctum into the canaliculus and toward the nasolacrimal duct. – Depending on the stent design, it may be secured within the canaliculus (monocanalicular) or passed through both upper and lower canaliculi and retrieved in the nose (bicanalicular). – The clinician ensures the stent sits without excessive tension.
Immediate checks – Confirmation of appropriate position. – Basic assessment for bleeding, discomfort, and tube stability.
Follow-up – Monitoring for irritation, displacement, infection, or granulation tissue. – Planned removal when the clinician determines healing is adequate (timing varies by clinician and case).

This overview is intentionally general; procedural specifics (instruments, retrieval methods, and exact steps) vary by technique, training, and anatomy.

Types / variations

nasolacrimal intubation is not a single uniform method. Variations relate to where the obstruction is, how much of the system is stented, and how the stent is anchored.

Common categories include:

Monocanalicular stents
Typically placed through one punctum and anchored at the eyelid margin.
Often used when the goal is to stent a single canaliculus or to avoid a nasal retrieval step.
May be considered in certain pediatric cases or punctal/canalicular issues, depending on clinician preference.
Bicanalicular stents
Passed through both upper and lower puncta, through the canaliculi, and into the nose, then secured (often by tying or using a fixation method).
Often used for canalicular lacerations, more complex stenosis, or to stent a larger portion of the drainage pathway.
Intubation as an adjunct to other procedures
After DCR: a stent may be placed to support the new drainage opening (whether to stent routinely varies by surgeon and case).
With probing or dilation: intubation can follow probing when narrowing is more persistent or recurrent.
Material and design differences
Most stents are silicone, but exact softness, diameter, surface finish, and fixation components vary by material and manufacturer.
Some systems use a guiding probe or retrieval thread; others use different introducer designs.
Diagnostic vs therapeutic role
Intubation is primarily therapeutic (intended to improve drainage), but the ability to pass instruments through the system can also provide information about the site and character of obstruction during evaluation.

Pros and cons

Pros:

Can provide symptom improvement in selected tear drainage obstructions.
Temporarily supports healing and reduces re-narrowing risk in some postoperative settings.
Often less invasive than creating a new drainage bypass pathway, depending on the alternative.
Useful in canalicular trauma repair to preserve the natural drainage route.
Removable when no longer needed (timing varies by clinician and case).
Can be used in children and adults, with technique adjustments.

Cons:

Irritation or foreign-body sensation can occur, especially if the tube rubs the eye surface.
Displacement or loss of the stent is possible (e.g., tube prolapse or nasal movement).
Infection or inflammation can develop around the stent in some cases.
Granulation tissue (localized overgrowth of healing tissue) may form near puncta or within the nose.
Incomplete symptom relief may occur if tearing is due to eyelid mechanics, ocular surface disease, or complete obstruction.
Requires follow-up and removal, and outcomes can vary by clinician and case.

Aftercare & longevity

After placement, clinicians usually monitor comfort, tube position, and signs of inflammation. The exact aftercare plan differs depending on whether intubation was done for congenital obstruction, adult stenosis, trauma repair, or as part of a larger procedure.

Factors that can influence outcomes and “longevity” of benefit include:

Location and severity of obstruction: partial narrowing behaves differently than complete blockage.
Underlying cause: inflammation-related stenosis, scarring, congenital narrowing, or trauma may have different recurrence tendencies.
Ocular surface health: dry eye, blepharitis (eyelid inflammation), and chronic conjunctivitis can worsen irritation and tearing, and can complicate symptom interpretation.
Eyelid position and lacrimal pump function: blinking mechanics and lid laxity can affect drainage even if the pathway is open.
Stent type and fit: tension, tube size, and anchoring method can affect comfort and stability; details vary by material and manufacturer.
Follow-up adherence: monitoring helps identify displacement, infection, or tissue overgrowth early (what follow-up is needed varies by clinician and case).
Comorbid nasal conditions: nasal inflammation or anatomical crowding can affect tolerance and stability for stents that traverse into the nose.

When the tube is removed, some people maintain improved drainage, while others experience recurrent tearing over time. Recurrence risk is influenced by the same factors above and by tissue healing patterns, which vary among individuals.

Alternatives / comparisons

Excess tearing has multiple causes, so alternatives depend on what testing shows: an anatomic blockage, a functional drainage problem, eyelid malposition, or reflex tearing from ocular surface irritation.

Common comparisons include:

Observation / monitoring
In some pediatric cases, tear duct obstruction can improve with growth, and clinicians may monitor before procedural intervention (timing varies by clinician and case).
In adults, observation may be reasonable when symptoms are mild or intermittent and no infection is present.
Medical management
If tearing is driven by ocular surface inflammation (dry eye, allergy, blepharitis), treating surface disease may reduce reflex tearing.
Medications do not “open” a structurally blocked nasolacrimal duct, but they can reduce inflammation-related components.
Simple probing and irrigation
Often considered earlier in congenital obstruction and sometimes in adults with focal narrowing.
Intubation may be used if probing alone is insufficient or if narrowing is more persistent (varies by clinician and case).
Balloon dilation (balloon dacryoplasty)
Uses a small balloon to dilate narrowed segments.
Sometimes combined with intubation, depending on anatomy and clinician preference.
Punctoplasty or punctal dilation
If the main issue is punctal stenosis (narrow punctal opening), procedures focused on enlarging the punctum may be considered.
Intubation may be added if canalicular narrowing is also present.
Dacryocystorhinostomy (DCR)
A surgical bypass that creates a new drainage route from the lacrimal sac into the nasal cavity.
Often considered for nasolacrimal duct obstruction that is complete, recurrent, or unlikely to respond to less invasive steps.
Some surgeons place a stent during DCR; others do not routinely, and practice varies.
Eyelid surgery (for malposition)
When tearing is due to ectropion, entropion, or lid laxity affecting the lacrimal pump, eyelid tightening or repositioning may address the root cause more directly than stenting.

In practice, clinicians choose among these based on the site of obstruction, symptom severity, infection history, and patient-specific anatomy.

nasolacrimal intubation Common questions (FAQ)

Q: Is nasolacrimal intubation the same as tear duct surgery?
nasolacrimal intubation is a tear drainage procedure, but it is not the same as all tear duct surgeries. It typically places a temporary stent within the existing drainage system. Other surgeries, such as DCR, create or enlarge a drainage opening into the nose.

Q: Will it hurt?
Discomfort varies by clinician and case, and by the type of anesthesia used. Many people describe irritation or awareness of the tube rather than sharp pain. If discomfort is significant, clinicians typically evaluate tube position and ocular surface health.

Q: How long does the tube stay in?
The intended duration depends on why it was placed (for example, congenital obstruction vs trauma repair vs postoperative support). Clinicians often plan removal after a healing period, but the timeline varies by clinician and case. Removal timing may also change if the tube displaces or causes irritation.

Q: Can you see the tube in the eye?
Sometimes a small segment is visible near the punctum or at the inner corner, depending on the stent type. Many stents are designed to be minimally noticeable, but visibility varies with anatomy and placement. If a loop becomes more visible over time, it can indicate displacement.

Q: What happens if the stent falls out or moves?
Stent displacement can occur and may affect comfort and effectiveness. If it moves substantially, clinicians may assess whether it needs repositioning or replacement. The urgency and next steps vary by clinician and case.

Q: Does nasolacrimal intubation fix watery eyes permanently?
It can lead to lasting improvement in some people, especially when narrowing resolves during healing. In others, tearing can return after removal if scarring or dysfunction persists. Long-term results depend on the cause and location of obstruction and individual healing.

Q: Is it considered safe?
In trained hands, it is a commonly performed lacrimal procedure. As with any intervention, risks exist, including irritation, infection, bleeding from the nose, or tissue overgrowth around the stent. Individual risk depends on anatomy, indication, and overall health, and varies by clinician and case.

Q: Will I need time off work or school?
Downtime depends on the setting (clinic-based vs operating room), anesthesia type, and whether other procedures were performed at the same time. Some people return to routine activities relatively quickly, while others need more recovery time. Expectations vary by clinician and case.

Q: Can I drive or use screens afterward?
Driving and screen use depend mainly on vision clarity, comfort, and whether sedating medications or anesthesia were used. Some people have temporary tearing, blur from drops, or irritation that affects visual comfort. Clinicians typically provide activity guidance tailored to the situation, which varies by clinician and case.

Q: How much does nasolacrimal intubation cost?
Costs vary widely based on region, facility fees, anesthesia type, and whether it is combined with other procedures. Insurance coverage and coding also affect out-of-pocket cost. For cost expectations, clinics typically provide an estimate based on the planned setting and approach.